Current Status and Evaluation of Randomized Clinical Trials of Traditional Chinese Medicine in the Treatment of Cardiovascular Diseases

Table 1

Characteristics of included RCTs on hypertension.

Researcher	Diagnostic criteria	Sample size		Intervention		Follow-up period	Outcome
		Experiment	Control	Experiment	Control
Dongyan Zhang	Chinese guidelines for the management of hypertension	126	125	Gastrodia-Uncaria granules	Placebo	4 weeks	Daytime and 24-hour BP decreased
Shuhua Wang	Chinese guidelines for the management of hypertension + TCM syndrome differentiation	160	80	Tiankuijiangya tablet + standard treatment	Placebo + standard treatment	8 weeks	Reduction of BP
Chunxiao Wu	Chinese guidelines for the management of hypertension	100	50	Bushen Qinggan Formula + standard treatment	Placebo + standard treatment	8 weeks	BPD and BPV decreased
Jinpeng Ma	Chinese guidelines for the management of hypertension	54	64	Qiqilian Capsule + standard treatment	Placebo + standard treatment	4 weeks	Reduction of BP
Xudong Liu	Chinese guidelines for the management of hypertension + TCM syndrome differentiation	52	51	Jingui Shenqi pill + standard treatment	Standard treatment	6 weeks	Reduction of BP
Xi Chen	Chinese guidelines for the management of hypertension + TCM syndrome differentiation	99	100	Jiangyabao tablet + standard treatment	Placebo + standard treatment	24 weeks	Reduction of BP
Hui Zheng	Chinese guidelines for the management of hypertension + JNC‐7	107(2 experiment groups)	107(2 control groups)	Affected acupuncture point, nonaffected acupuncture point	Sham acupuncture, waiting‐list control	12 weeks	Minor reduction of BP